[PHARMA] QoQ Quarter Result on 31-Mar-2021 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
21-May-2021
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Mar-2021 [#1]
Profit Trend
QoQ- 465.44%
YoY- 3.29%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Revenue 711,718 2,132,675 1,177,123 793,499 634,583 624,804 645,763 6.67%
PBT 125,088 98,219 22,244 31,524 -13,506 4,093 14,326 322.35%
Tax -39,923 -47,895 -8,356 -8,696 6,459 -2,799 -4,719 313.58%
NP 85,165 50,324 13,888 22,828 -7,047 1,294 9,607 326.63%
-
NP to SH 85,475 49,835 13,704 23,136 -6,331 1,442 9,979 316.99%
-
Tax Rate 31.92% 48.76% 37.57% 27.59% - 68.39% 32.94% -
Total Cost 626,553 2,082,351 1,163,235 770,671 641,630 623,510 636,156 -1.00%
-
Net Worth 450,411 391,428 357,275 355,919 337,298 345,040 357,891 16.51%
Dividend
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Div 65,466 26,182 19,630 10,468 2,614 3,920 6,530 362.99%
Div Payout % 76.59% 52.54% 143.25% 45.25% 0.00% 271.91% 65.45% -
Equity
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Net Worth 450,411 391,428 357,275 355,919 337,298 345,040 357,891 16.51%
NOSH 1,309,336 1,309,126 261,991 261,705 261,705 261,705 261,705 191.66%
Ratio Analysis
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
NP Margin 11.97% 2.36% 1.18% 2.88% -1.11% 0.21% 1.49% -
ROE 18.98% 12.73% 3.84% 6.50% -1.88% 0.42% 2.79% -
Per Share
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 54.36 162.91 89.95 303.20 242.70 239.03 247.20 -63.46%
EPS 6.53 3.81 1.05 8.84 -2.42 0.55 3.82 42.82%
DPS 5.00 2.00 1.50 4.00 1.00 1.50 2.50 58.53%
NAPS 0.344 0.299 0.273 1.36 1.29 1.32 1.37 -60.09%
Adjusted Per Share Value based on latest NOSH - 261,705
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
RPS 49.38 147.97 81.67 55.06 44.03 43.35 44.81 6.66%
EPS 5.93 3.46 0.95 1.61 -0.44 0.10 0.69 317.92%
DPS 4.54 1.82 1.36 0.73 0.18 0.27 0.45 364.94%
NAPS 0.3125 0.2716 0.2479 0.247 0.234 0.2394 0.2483 16.51%
Price Multiplier on Financial Quarter End Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 -
Price 0.74 0.835 5.29 3.26 5.00 4.32 2.22 -
P/RPS 1.36 0.51 5.88 1.08 2.06 1.81 0.90 31.58%
P/EPS 11.34 21.93 505.18 36.88 -206.50 783.09 58.12 -66.25%
EY 8.82 4.56 0.20 2.71 -0.48 0.13 1.72 196.48%
DY 6.76 2.40 0.28 1.23 0.20 0.35 1.13 228.47%
P/NAPS 2.15 2.79 19.38 2.40 3.88 3.27 1.62 20.70%
Price Multiplier on Announcement Date
31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 CAGR
Date 17/02/22 19/11/21 20/08/21 21/05/21 17/03/21 19/11/20 19/08/20 -
Price 0.76 0.845 0.925 4.03 3.49 5.72 4.42 -
P/RPS 1.40 0.52 1.03 1.33 1.44 2.39 1.79 -15.07%
P/EPS 11.64 22.20 88.34 45.59 -144.14 1,036.87 115.71 -78.27%
EY 8.59 4.51 1.13 2.19 -0.69 0.10 0.86 361.85%
DY 6.58 2.37 1.62 0.99 0.29 0.26 0.57 408.50%
P/NAPS 2.21 2.83 3.39 2.96 2.71 4.33 3.23 -22.29%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment